Biomarkers Market Fueled by Precision Medicine Growth and Expansion of Companion Diagnostics | Thermo Fisher Scientific Inc., QIAGEN NV, Merck KGaA, BRUKER CORPORATION

The global Biomarkers market reached US$ 60.76 billion in 2024 and is expected to reach US$ 148.88 billion by 2032, growing at a CAGR of 11.9% during the forecast period 2025-2032.

Biomarkers Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With precision medicine on the rise, growing reliance on companion diagnostics, and biomarker discovery in oncology and neurology, the report delivers strategic insights for stakeholders across drug development and diagnostics from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/biomarkers-market?ophp

Biomarkers are measurable indicators of biological states used for diagnosis, prognosis, and treatment response. The global biomarker market is growing rapidly due to their expanding applications in personalized medicine, oncology, neurology, and drug development. Companion diagnostics and liquid biopsy innovations are major contributors to this growth.

Biomarkers Market Competitors Overview:

Thermo Fisher Scientific Inc., QIAGEN NV, Merck KGaA, BRUKER CORPORATION, Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Abbott Laboratories, Agilent Technologies Inc., Myriad Genetics and Somru BioScience Inc. among others.

Important Industry Updates of 2023, 2024 and 2025:

✅ January 28, 2025 - Quibim, based in Valencia, secured €50 million to scale its AI-powered imaging biomarker solutions (QP-Prostate, QP-Brain) aimed at enhancing precision diagnostics in cancer and neurology.

✅ Mid-2025 - Everlab, a Melbourne-based diagnostic innovator, raised US $15 million to boost its biomarker-driven preventive health platform, focusing on scaling operations and expanding technology capabilities.

✅ July 9, 2025 - Quanterix finalized the acquisition of Akoya Biosciences, forming a unified platform capable of analyzing protein biomarkers in both blood and tissue, growing its target market from US $1 billion to US $5 billion.

✅ May 2025 - The FDA approved Roche's Elecsys PRO‐C3, a diagnostic tool for liver fibrosis, and the VENTANA MET RxDx assay to support MET-targeted therapy decisions in non-small cell lung cancer (NSCLC).

Methodology and Scope

The Biomarkers Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biomarkers-market?ophp

Biomarkers Market Segments Overview:

∎ By Type (Diagnostic Biomarkers, Monitoring Biomarkers, Predictive Biomarkers, Susceptibility/Risk Biomarkers, Prognostic Biomarkers, Pharmacodynamic/Response Biomarkers, Safety Biomarkers, Others)
∎ By Product Type (Assays, Kits, Reagents, Others)
∎ By Application (Drug Discovery and Development, Disease Diagnostics, Disease Risk Assessment, Personalized Medicine, Others)
∎ By End-User (Pharmaceutical Companies, Biotechnology Companies, Research Centers and Institutes, Others)

The oncology biomarkers segment leads the market, driven by the demand for precision cancer therapies and early detection through companion diagnostics.

Regional Overview for Biomarkers Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America is the largest market for biomarkers, supported by advanced research infrastructure and demand for personalized medicine. Asia Pacific is the fastest growing region, with increasing clinical trials, government support, and expanding biotech sectors.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=biomarkers-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Biomarkers market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Biomarkers market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.